ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500672 announcements Novartis announcements and dividends declared BSE

Novartis Complete list of announcements declared & dividend announcements by Novartis 500672

Novartis 500672 listed on BSE and deals in

Announcements and dividends declared by Novartis 500672

US FDA approves Novartis' gene therapy for rare muscle disorder
The US FDA has approved Novartis' new gene therapy, Itvisma, which is for patients aged two and above with spinal muscular atrophy. Itvisma offers a new option for a broader patient group. The therapy aims to replace a faulty gene crucial for muscle functi
Announcement as on 25 November 2025

Novartis AG Basel Reaches Analyst Target Price
In recent trading, shares of Novartis AG Basel (Symbol: NVS) have crossed above the average analyst 12-month target price of 7.00, changing hands for 7.11/share. When a stock reaches the target an analyst has set, the analyst logically has two ways
Announcement as on 11 November 2025

Novartis To Acquire Avidity Biosciences In Bln Deal
(RTTNews) - Novartis AG (NVS, NOVN.SW) announced that it has entered into a definitive agreement to acquire Avidity Biosciences Inc. (RNA) for .00 per share in cash, valuing the company at approximately .0 billion on a fully diluted basis. The transa
Announcement as on 27 October 2025

In major move, patent of Novartis' blockbuster cardiac drug revoked by India
The Indian Patent Office revoked Novartis' patent for Vymada, a heart failure drug, citing a lack of novelty and inventive step. This decision paves the way for generic versions, potentially lowering treatment costs for Indian patients. Domestic pharmaceut
Announcement as on 16 September 2025

Novartis' Moonshot Cancer Therapy Could Be Future Growth Driver
GLP-1 drugs are taking much oxygen out of the biotechnology trade. However, many investors have been eyeing other areas in the sector, particularly cancer research. Novartis AG (NYSE: NVS) is up over 31% in 2025, and a novel cancer treatment could giv
Announcement as on 09 September 2025

Announcements by Novartis first page | Next page |

500672 Novartis current price & indicator signals

Moving Averages for Novartis

  • 5Day Average: 802.32
  • 12Day Average: 811.44
  • 20Day Average: 818.85
  • 50Day Average: 850.24
  • 100Day Average: 904.85
  • 150Day Average: 925.26
  • 200Day Average: 896.42

500672 Indicators & signals

Indicator MACD (12,26,9)

809.46, 825.49, -14.84
Indicator MACD is in negative zone

Indicator ADX (14)

55.75, 8.09, 28.49
Indicator ADX is indicating that momentum is still strong.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 47
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500672 Novartis are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 784.35 780.50 to 801.10 -1.6% 0.89 times
04 Thu Dec 2025 797.10 790.00 to 813.10 -1.48% 7.42 times
03 Wed Dec 2025 809.10 808.20 to 815.00 -0.12% 0.23 times
02 Tue Dec 2025 810.10 808.05 to 816.00 -0.1% 0.22 times
01 Mon Dec 2025 810.95 805.50 to 816.85 0.4% 0.2 times
28 Fri Nov 2025 807.75 792.30 to 819.00 -0.48% 0.39 times
27 Thu Nov 2025 811.65 805.00 to 819.00 -0.02% 0.25 times
26 Wed Nov 2025 811.80 809.40 to 823.90 0.19% 0.44 times
25 Tue Nov 2025 810.30 809.65 to 824.95 -1.4% 0.54 times
24 Mon Nov 2025 821.80 818.00 to 839.95 -1.12% 0.14 times
21 Fri Nov 2025 831.10 828.10 to 840.00 -0.02% 0.16 times
20 Thu Nov 2025 831.30 818.00 to 840.05 0.82% 0.36 times

Videos related to: 500672 announcements Novartis announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

500672 announcements Novartis announcements and dividends declared BSE

 

Back to top